SunLink Health Systems, Inc.
SSY · AMEX
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | -0.01 | 0.02 | -0.00 |
| FCF Yield | 0.00% | -21.64% | -16.24% | -13.57% |
| EV / EBITDA | -0.78 | 2.07 | 1.60 | 3.86 |
| Quality | ||||
| ROIC | -4.71% | -6.89% | -9.20% | -4.03% |
| Gross Margin | 68.93% | 37.19% | 39.06% | 40.30% |
| Cash Conversion Ratio | 0.69 | – | – | -0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.42% | -9.58% | -5.98% | -7.77% |
| Free Cash Flow Growth | 0.00% | -46.56% | -19.76% | 42.43% |
| Safety | ||||
| Net Debt / EBITDA | 21.86 | 11.08 | 8.00 | 25.35 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.56 | 5.22 | 3.12 | 3.04 |
| Cash Conversion Cycle | 35.70 | 36.58 | 38.10 | 31.63 |